Doylestown, PA, United States of America

Christopher Phillips

USPTO Granted Patents = 12 (Patent Applications = 7)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 80(Granted Patents)

Location History:

Doylestown, PA (US) (2017 - 2020)
Doyleston, PA (US) (2013 - 2021)

Company Filing History:

6 out of 20

Aclaris Therapeutics, Inc.

Elan Pharmaceuticals, Inc.

Servier IP UK Limited

Years Active: 2013-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12343387 - Formulations of polyalkylene oxide-asparaginase and methods of making and using the same (2025-07-01),

2. 12290506 - Compositions and formulations for use of a PK inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders (2025-05-06),

3. 10954303 - Immunoglobulin formulation and method of preparation thereof (2021-03-23),

4. 10729720 - Peroxide formulations and methods and applicators for using the same (2020-08-04),

5. 10653721 - Peroxide formulations and methods and applicators for using the same (2020-05-19),

6. 10493103 - Peroxide formulations and methods and applicators for using the same (2019-12-03),

7. 10098910 - Peroxide formulations and methods and applicators for using the same (2018-10-16),

8. 9980983 - Peroxide formulations and methods and applicators for using the same (2018-05-29),

9. 9675639 - Peroxide formulations and methods and applicators for using the same (2017-06-13),

10. 8900577 - Immunoglobulin formulation and method of preparation thereof (2014-12-02),

11. 8815236 - Method for treating multiple sclerosis and crohn's disease (2014-08-26),

12. 8349321 - Immunoglobulin formulation and method of preparation thereof (2013-01-08),

Title: Christopher Phillips: A Pioneer in Innovative Skin Treatment Solutions

Introduction: Christopher Phillips, a visionary inventor based in Doylestown, PA, is a beacon of inspiration in the realm of innovation. With a steadfast commitment to driving progress and a fervent dedication to developing cutting-edge technologies, he serves as a role model for aspiring inventors around the world.

Latest Patents: With an impressive portfolio of 6 patents to his name, Christopher's latest groundbreaking patents revolve around peroxide formulations and methods alongside applicators for their application. These formulations encompass stabilized hydrogen peroxide and 2-propanol, specifically designed to treat various skin conditions like warts, molluscum contagiosum, and seborrheic keratosis. The versatile applicators are tailored for storing, dispensing, and efficiently applying these stable compositions, catering to a wide range of treatment scenarios.

Career Highlights: Christopher Phillips excels in his role at Aclaris Therapeutics, Inc., a prominent player in the field of innovative therapeutic solutions. His remarkable contributions have significantly impacted the advancement of skin treatment technologies, showcasing his prowess as a forward-thinker and problem solver within the industry.

Collaborations: Within the collaborative landscape, Christopher has worked alongside esteemed professionals like Stuart D. Shanler and Christopher Powala, further enhancing his inventive capabilities and fostering a culture of innovation within his professional network.

Conclusion: Christopher Phillips' unwavering pursuit of innovation and his trailblazing approach to inventing novel treatment solutions underscore his position as a true luminary in the field. His work not only revolutionizes the way we approach skin treatments but also sets a high standard for ingenuity, creativity, and perseverance in the realm of invention.

This text is generated by artificial intelligence and may not be accurate.